Varicella-zoster virus strain oka/merck live antigen
- Listing at source
- Listed
- Drug name
- Varicella-zoster virus strain oka/merck live antigen
- m m r ii and varivax
- measles mumps rubella and varicella oka merck virus vaccine live
- measles mumps rubella and varicella oka merck virus vaccine live proquad
- Varicella (Oka-Merck) Virus Vaccine Live (ProQuad)
- varicella (Oka/Merck) virus vaccine live
- varicella oka merck virus vaccine live
- varicella oka merck virus vaccine live proquad
- varicella vaccine
- Varicella vaccine
- Varicella Vaccine
- varicella vaccine (VARIVAX)
- varicella vaccine varivax
- Varicella Virus Vaccine (Live)
- varicella virus vaccine live
- Varicella Virus Vaccine Live
- Varicella Virus Vaccine Live (Oka-Merck)
- varicella virus vaccine live oka merck
- varivax
- Varivax
- VARIVAX
- varivax provarivax
- Varivax®
- VARIVAX®
- Varivax™
- VARIVAX™
And 6 more, listed on the interactive page.
- FDA ingredient codes (UNII)
- GPV39ZGD8C
Related records
Trials (26)
- A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.
- A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)
- A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2)
- A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)
- A Study of ProQuad™ in Healthy Children in Korea (V221-023)
- A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062)
- An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children
- Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine
- Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM
- Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox
- Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)
- Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063)
- Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients
- Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines
- Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines
- Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against Chickenpox
- Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children
- Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age
- ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)
- Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients